4th Annual Pharma R&D Asia Congress 2014
27 Feb 2014 - 28 Feb 2014 - Shanghai, China
The booming growth of research and development activities
in Asia and Asia Pacific regions has advanced the opportunity for business
success. Industry leaders believe that the Asian market will overtake the US by
2020. Our conference will bring together industry leaders to discuss the
potential and future of the R&D industry. Our exclusive networking sessions
will offer opportunities to meet with potential partners and form unique
Expert speakers will discuss strategies to advance
research and development activities in Asia. They will offer insights into the
importance of collaborations between eastern and western countries for
advancing global drug development. Topics will also cover methods to choose
correct outsourcing partners for business needs, attaining successful mergers
and acquisitions and opportunities for multi-national companies in emerging
Confirmed Speakers Include:
Yariv Hefez, VP, Merck, Switzerland
Beverly Lui, Director, Amgen, China
Jian Li, Director, Global R&D Sanofi, China
Yuan-Hua Ding, Senior Director, Pfizer Worldwide
Simon McErlane, Senior Medical, Takeda Development
Center Asia, Singapore
To view full list of speakers, click here.
The event will provide the opportunity for networking and
knowledge sharing in the expanding clinical market in Asia and Asia Pacific
regions. Over the two days the event will attract over 150 senior-level
international decision makers working in discovery, R&D, translational
sciences, medical affairs and outsourcing & partnerships from pharma and
biotech companies in Asia, Australia, the USA and Europe.
To download agenda, please click here.
Please contact Freda Shi at +65 6570 2208 or email firstname.lastname@example.org to express your interest today!